Suppr超能文献

一种具有随机效应的相称先验模型,用于生存和竞争风险结果以纳入历史对照。

A Commensurate Prior Model With Random Effects for Survival and Competing Risk Outcomes to Accommodate Historical Controls.

作者信息

Khanal Manoj, Logan Brent R, Banerjee Anjishnu, Fang Xi, Ahn Kwang Woo

机构信息

Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Department of Biostatistics, Yale University, New Haven, Connecticut, USA.

出版信息

Pharm Stat. 2025 Jan-Feb;24(1):e2464. doi: 10.1002/pst.2464.

Abstract

Clinical trials (CTs) often suffer from small sample sizes due to limited budgets and patient enrollment challenges. Using historical data for the CT data analysis may boost statistical power and reduce the required sample size. Existing methods on borrowing information from historical data with right-censored outcomes did not consider matching between historical data and CT data to reduce the heterogeneity. In addition, they studied the survival outcome only, not competing risk outcomes. Therefore, we propose a clustering-based commensurate prior model with random effects for both survival and competing risk outcomes that effectively borrows information based on the degree of comparability between historical and CT data. Simulation results show that the proposed method controls type I errors better and has a lower bias than some competing methods. We apply our method to a phase III CT which compares the effectiveness of bone marrow donated from family members with only partially matched bone marrow versus two partially matched cord blood units to treat leukemia and lymphoma.

摘要

由于预算有限和患者招募困难,临床试验(CTs)常常面临样本量较小的问题。使用历史数据进行CT数据分析可能会提高统计功效并减少所需的样本量。现有的利用带有右删失结局的历史数据来借鉴信息的方法没有考虑历史数据与CT数据之间的匹配以减少异质性。此外,它们仅研究了生存结局,而非竞争风险结局。因此,我们提出了一种基于聚类的相称先验模型,该模型对生存和竞争风险结局均具有随机效应,能基于历史数据与CT数据之间的可比程度有效地借鉴信息。模拟结果表明,与一些竞争方法相比,所提出的方法能更好地控制I型错误且偏差更低。我们将我们的方法应用于一项III期CT,该试验比较了来自家庭成员的仅部分匹配的骨髓与两个部分匹配的脐血单位治疗白血病和淋巴瘤的有效性。

相似文献

2
Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior.
Pharm Stat. 2022 Sep;21(5):818-834. doi: 10.1002/pst.2195. Epub 2022 Feb 6.
3
A novel power prior approach for borrowing historical control data in clinical trials.
Stat Methods Med Res. 2023 Mar;32(3):493-508. doi: 10.1177/09622802221146309. Epub 2023 Jan 4.
4
Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
Stat Med. 2021 Jun 30;40(14):3385-3399. doi: 10.1002/sim.8970. Epub 2021 Apr 13.
5
Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
Pharm Stat. 2022 Sep;21(5):1074-1089. doi: 10.1002/pst.2203. Epub 2022 Mar 12.
6
Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
Pharm Stat. 2020 Sep;19(5):613-625. doi: 10.1002/pst.2018. Epub 2020 Mar 17.
7
An efficient Bayesian platform trial design for borrowing adaptively from historical control data in lymphoma.
Contemp Clin Trials. 2020 Feb;89:105890. doi: 10.1016/j.cct.2019.105890. Epub 2019 Nov 15.
8
Potential Bias Models With Bayesian Shrinkage Priors for Dynamic Borrowing of Multiple Historical Control Data.
Pharm Stat. 2025 Mar-Apr;24(2):e2453. doi: 10.1002/pst.2453. Epub 2024 Nov 17.
9
Elastic priors to dynamically borrow information from historical data in clinical trials.
Biometrics. 2023 Mar;79(1):49-60. doi: 10.1111/biom.13551. Epub 2021 Sep 20.

本文引用的文献

1
Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes.
Transplant Cell Ther. 2022 Feb;28(2):109.e1-109.e8. doi: 10.1016/j.jtct.2021.11.002. Epub 2021 Nov 11.
2
Immortal Time Bias in Observational Studies.
JAMA. 2021 Feb 16;325(7):686-687. doi: 10.1001/jama.2020.9151.
4
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.
J Clin Oncol. 2021 Jun 10;39(17):1865-1877. doi: 10.1200/JCO.20.01086. Epub 2021 Jan 15.
5
Borrowing of information across patient subgroups in a basket trial based on distributional discrepancy.
Biostatistics. 2022 Jan 13;23(1):120-135. doi: 10.1093/biostatistics/kxaa019.
7
Bayesian leveraging of historical control data for a clinical trial with time-to-event endpoint.
Stat Med. 2020 Mar 30;39(7):984-995. doi: 10.1002/sim.8456. Epub 2020 Jan 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验